JPH01156969A - 酢酸誘導体およびその塩 - Google Patents

酢酸誘導体およびその塩

Info

Publication number
JPH01156969A
JPH01156969A JP63295323A JP29532388A JPH01156969A JP H01156969 A JPH01156969 A JP H01156969A JP 63295323 A JP63295323 A JP 63295323A JP 29532388 A JP29532388 A JP 29532388A JP H01156969 A JPH01156969 A JP H01156969A
Authority
JP
Japan
Prior art keywords
salt
salts
acid
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63295323A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0316351B2 (enExample
Inventor
Takao Takatani
高谷　隆男
Hisashi Takasugi
高杉　寿
Masayoshi Murata
正好 村田
Akiteru Yoshioka
吉岡　明昭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPH01156969A publication Critical patent/JPH01156969A/ja
Publication of JPH0316351B2 publication Critical patent/JPH0316351B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
JP63295323A 1980-12-31 1988-11-22 酢酸誘導体およびその塩 Granted JPH01156969A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8041639 1980-12-31
GB8041639 1980-12-31
GB8121557 1981-07-13
GB8121557 1981-07-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP14082A Division JPS57131795A (en) 1980-12-31 1981-12-25 Novel cephem compound and salt thereof, preparation of the same and preventing agent and remedy for microbism

Publications (2)

Publication Number Publication Date
JPH01156969A true JPH01156969A (ja) 1989-06-20
JPH0316351B2 JPH0316351B2 (enExample) 1991-03-05

Family

ID=26278011

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63295323A Granted JPH01156969A (ja) 1980-12-31 1988-11-22 酢酸誘導体およびその塩

Country Status (4)

Country Link
US (1) US4427677A (enExample)
EP (1) EP0055466B1 (enExample)
JP (1) JPH01156969A (enExample)
DE (1) DE3176154D1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3177090D1 (en) * 1980-12-31 1989-09-28 Fujisawa Pharmaceutical Co 7-acylaminocephalosporanic acid derivatives and processes for the preparation thereof
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
EP1059293A1 (en) * 1995-10-12 2000-12-13 Microcide Pharmaceuticals, Inc. Novel amino chlorothiazole compounds
TWI335332B (en) * 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
TW200305422A (en) * 2002-03-18 2003-11-01 Shionogi & Co Broad spectrum cefem compounds
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760484C2 (enExample) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
DE2758001A1 (de) * 1977-12-24 1979-07-12 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
AR229883A1 (es) 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
US4329453A (en) 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic
DE3006888A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP0055466A3 (en) 1983-11-16
JPH0316351B2 (enExample) 1991-03-05
DE3176154D1 (en) 1987-06-11
EP0055466A2 (en) 1982-07-07
US4427677A (en) 1984-01-24
EP0055466B1 (en) 1987-05-06

Similar Documents

Publication Publication Date Title
JPH03135973A (ja) アミノチアゾリル酢酸類
JPH0127076B2 (enExample)
JPS6341913B2 (enExample)
JPH0316351B2 (enExample)
JPS6238357B2 (enExample)
EP0036510B1 (en) Synisomer cephalosporin compounds and processes for their preparation
JPH037296A (ja) 新規複素環置換酢酸誘導体
JPH0242829B2 (enExample)
EP0082498A2 (en) Beta-lactam compounds and process for the preparation thereof
JPH0144715B2 (enExample)
JPH0121154B2 (enExample)
JPS6133836B2 (enExample)
JPH02790A (ja) ７―［２―（２―アミノチアゾール―４―イル）―２―ヒドロキシイミノアセトアミド］―３―セフェム化合物の製造法
JPS6361954B2 (enExample)
JPH0214358B2 (enExample)
US4358448A (en) N-substituted thiazolyl derivatives of oxy-imino-substituted cephalosporins useful as anti-bacterial agents
JPH0521912B2 (enExample)
JPS63211286A (ja) β−ラクタム誘導体
JPS6341914B2 (enExample)
JPH0359076B2 (enExample)
JPH051271B2 (enExample)
JPH0144716B2 (enExample)
KR840001616B1 (ko) 새로운 세펨화합물의 제조 방법
JPH0414117B2 (enExample)
JPS6135198B2 (enExample)